PT  - JOURNAL ARTICLE
AU  - ,
AU  - Tas, Jeanette
AU  - van Gassel, Rob J.J.
AU  - Heines, Serge J.H.
AU  - Mulder, Mark M.G.
AU  - Heijnen, Nanon F.L.
AU  - Jong, Melanie J. Acampo-de
AU  - Bels, Julia L.M.
AU  - Bennis, Frank C.
AU  - Koelmann, Marcel
AU  - Groven, Rald V.M.
AU  - Donkers, Moniek A.
AU  - van Rosmalen, Frank
AU  - Hermans, Ben J.M.
AU  - Meex, Steven J.R.
AU  - Mingels, Alma M.A.
AU  - Bekers, Otto
AU  - Savelkoul, Paul H.M.
AU  - Oude Lashof, Astrid M.L
AU  - Wildberger, Joachim E.
AU  - ,
AU  - Tijssen, Fabian H.
AU  - Buhre, Wolfgang F.F.A.
AU  - Sels, Jan-Willem E.M.
AU  - Ghossein-Doha, Chahinda
AU  - Driessen, Rob G.H.
AU  - Kubben, Pieter L.
AU  - Janssen, Marcus L.F.
AU  - Nicolaes, Gerry A.F.
AU  - Strauch, Uli
AU  - Geyik, Zafer
AU  - Delnoy, Thijs S.R.
AU  - Walraven, Kim H.M.
AU  - Stehouwer, Coen D.A.
AU  - Verbunt, Jeanine A.M.C.F.
AU  - van Mook, Walther N.K.A
AU  - Santen, Susanne van
AU  - Schnabel, Ronny M.
AU  - Aries, Marcel J.H.
AU  - van de Poll, Marcel C.G.
AU  - Bergmans, Dennis C.J.J
AU  - van der Horst, Iwan C.C.
AU  - van Kuijk, Sander M.J.
AU  - van Bussel, Bas C.T.
TI  - Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; <em>MaastrICCht</em>
AID  - 10.1101/2020.04.27.20080309
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.27.20080309
4099  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20080309.short
4100  - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20080309.full
AB  - Background The course of the disease in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in mechanically ventilated patients is unknown. To unravel the clinical heterogeneity of the SARS-CoV-2 infection in these patients, we designed the prospective observational Maastricht Intensive Care COVID cohort; MaastrICCht. We incorporated serial measurements that harbour aetiological, diagnostic and predictive information. The study aims to investigate the heterogeneity of the natural course of critically ill patients with SARS-CoV-2 infection.Study population Mechanically ventilated patients admitted to the Intensive Care with SARS- CoV-2 infection.Main message We will collect clinical variables, vital parameters, laboratory variables, mechanical ventilator settings, chest electrical impedance tomography, electrocardiograms, echocardiography as well as other imaging modalities to assess heterogeneity of the natural course of SARS-CoV-2 infection in critically ill patients. The MaastrICCht cohort is, also designed to foster various other studies and registries and intends to create an open-source database for investigators. Therefore, a major part of the data collection is aligned with an existing national Intensive Care data registry and two international COVID-19 data collection initiatives. Additionally, we create a flexible design, so that additional measures can be added during the ongoing study based on new knowledge obtained from the rapidly growing body of evidence.Conclusion The spread of the COVID-19 pandemic requires the swift implementation of observational research to unravel heterogeneity of the natural course of the disease of SARS- CoV-2 infection in mechanically ventilated patients. Our design is expected to enhance aetiological, diagnostic and prognostic understanding of the disease. This paper describes the design of the MaastrICCht cohort.Strengths and limitations of this studySerial measurements that characterize the disease course of SARS-CoV-2 infection in mechanically ventilated patientsData collection and analysis according to a predefined protocolFlexible, evolving design enabling the study of multiple aspects of SARS-CoV-2 infection in mechanically ventilated patientsSingle centre, including only ICU patientsCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNo trial ID because it is a prospective observational study.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData availability is not applicable for the protocol.